These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 12448966

  • 21. Factors influencing dopaminergic therapy of Parkinson's disease.
    Horowski R.
    Funct Neurol; 1988; 3(4):459-70. PubMed ID: 2907501
    [No Abstract] [Full Text] [Related]

  • 22. Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease.
    Merims D, Giladi N.
    Parkinsonism Relat Disord; 2008; 14(4):273-80. PubMed ID: 17988927
    [Abstract] [Full Text] [Related]

  • 23. Levodopa unresponsive symptoms in Parkinson disease.
    Sethi K.
    Mov Disord; 2008; 23 Suppl 3():S521-33. PubMed ID: 18781679
    [Abstract] [Full Text] [Related]

  • 24. A case of hedonistic homeostatic dysregulation.
    Kessel BL.
    Age Ageing; 2006 Sep; 35(5):540-1. PubMed ID: 16799178
    [Abstract] [Full Text] [Related]

  • 25. [Early treatment of Parkinson's disease with levodopa].
    Odekerken VJ, Post B, Verschuur CV, de Bie RM.
    Ned Tijdschr Geneeskd; 2009 Sep; 153():A286. PubMed ID: 19785822
    [Abstract] [Full Text] [Related]

  • 26. [Drug therapy of Parkinson's disease].
    Myllylä V.
    Duodecim; 1997 Sep; 113(18):1827-34. PubMed ID: 10892076
    [No Abstract] [Full Text] [Related]

  • 27. Levodopa for the treatment of Parkinson's disease.
    Lewitt PA.
    N Engl J Med; 2008 Dec 04; 359(23):2468-76. PubMed ID: 19052127
    [No Abstract] [Full Text] [Related]

  • 28. [Pseudopheochromocytoma in Parkinson disease and depression].
    Jähnel M.
    Psychiatr Prax; 2003 May 04; 30 Suppl 2():S64-5. PubMed ID: 14509040
    [Abstract] [Full Text] [Related]

  • 29. Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirements.
    Nutt JG.
    Neurology; 2006 May 23; 66(10):1611-2; author reply 1611-2. PubMed ID: 16717244
    [No Abstract] [Full Text] [Related]

  • 30. Drug insight: Continuous dopaminergic stimulation in the treatment of Parkinson's disease.
    Olanow CW, Obeso JA, Stocchi F.
    Nat Clin Pract Neurol; 2006 Jul 23; 2(7):382-92. PubMed ID: 16932589
    [Abstract] [Full Text] [Related]

  • 31. Addiction as aberrant learning-evidence from Parkinson's disease.
    Dagher A.
    Addiction; 2012 Feb 23; 107(2):248-50. PubMed ID: 22248132
    [No Abstract] [Full Text] [Related]

  • 32. Modern treatment of Parkinson's disease.
    Pearce JM.
    Br J Hosp Med; 1987 Jan 23; 37(1):59, 61, 64-6. PubMed ID: 3545340
    [Abstract] [Full Text] [Related]

  • 33. Current controversies: levodopa in the treatment of Parkinson's disease.
    Sharma JC, Vassallo M, Ross IN.
    Mov Disord; 2005 May 23; 20(5):642-3; author reply 643-4. PubMed ID: 15732129
    [No Abstract] [Full Text] [Related]

  • 34. Bilateral subthalamic nucleus stimulation results in reversal of alopecia in Parkinson's disease.
    Yamada K, Goto S.
    Parkinsonism Relat Disord; 2004 Aug 23; 10(6):353-5. PubMed ID: 15261876
    [Abstract] [Full Text] [Related]

  • 35. Recent advances in Parkinson's disease.
    Vécsei L.
    Ideggyogy Sz; 2002 Nov 20; 55(11-12):406-7. PubMed ID: 12632802
    [No Abstract] [Full Text] [Related]

  • 36. [Dopaminergic agents, COMT inhibitors or amantadine? Proper treatment for your Parkinson patient].
    Ceballos-Baumann AO.
    MMW Fortschr Med; 2002 May 06; Suppl 2():37-43. PubMed ID: 12070848
    [Abstract] [Full Text] [Related]

  • 37. Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease.
    Cools R.
    Neurosci Biobehav Rev; 2006 May 06; 30(1):1-23. PubMed ID: 15935475
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Levodopa in the treatment of Parkinson's disease: current controversies.
    Olanow CW, Agid Y, Mizuno Y, Albanese A, Bonuccelli U, Damier P, De Yebenes J, Gershanik O, Guttman M, Grandas F, Hallett M, Hornykiewicz O, Jenner P, Katzenschlager R, Langston WJ, LeWitt P, Melamed E, Mena MA, Michel PP, Mytilineou C, Obeso JA, Poewe W, Quinn N, Raisman-Vozari R, Rajput AH, Rascol O, Sampaio C, Stocchi F.
    Mov Disord; 2004 Sep 06; 19(9):997-1005. PubMed ID: 15372588
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.